J Balanant
Overview
Explore the profile of J Balanant including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
241
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Blondel B, Autret A, BRISAC C, Pelletier I, Martin-Latil S, Jegouic S, et al.
Med Trop (Mars)
. 2008 Jul;
68(2):189-202.
PMID: 18630055
Poliovirus, the aetiological agent of poliomyelitis, is an enterovirus of the Picronaviridae family. Despite the success of the World Health Organisation (WHO) worldwide vaccination campaign against poliomyelitis, poliovirus remains a...
2.
Haddad-Boubaker S, Ben Yahia A, Bahri O, Morel V, Balanant J, Delpeyroux F, et al.
J Clin Virol
. 2007 Nov;
41(2):81-6.
PMID: 18023246
Background: Genetic characterisation of polioviruses remains highly important even in countries where wild poliovirus circulation has been interrupted. Sequence data on representative wild strains from all geographical regions is required...
3.
Combiescu M, Guillot S, Persu A, Baicus A, Pitigoi D, Balanant J, et al.
Arch Virol
. 2007 Jan;
152(4):727-38.
PMID: 17195957
After intensive immunisation campaigns with the oral polio vaccine (OPV) as part of the Global Polio Eradication Initiative, poliomyelitis due to wild viruses has disappeared from most parts of the...
4.
Rousset D, Rakoto-Andrianarivelo M, Razafindratsimandresy R, Balanant J, Delpeyroux F
Med Mal Infect
. 2005 Jan;
34 Suppl 1:S65-6.
PMID: 15676252
No abstract available.
5.
Delpeyroux F, Guillot S, Szendroi A, Balanant J, Caro V, Cuervo N, et al.
Bull Soc Pathol Exot
. 2000 Oct;
93(3):193-7.
PMID: 11030056
To eradicate poliomyelitis and poliovirus, intensive vaccination campaigns with oral polio-vaccine (OPV) have been organised. Eradication campaigns may well be successful because the antiviral immunity and the local intestinal immunity...
6.
Georgescu M, Balanant J, MacAdam A, Otelea D, Combiescu M, Combiescu A, et al.
J Virol
. 1997 Oct;
71(10):7758-68.
PMID: 9311861
Attenuated strains of the Sabin oral poliovirus vaccine replicate in the human gut and in rare cases cause vaccine-associated paralytic poliomyelitis (VAPP). Reversion of vaccine strains toward a pathogenic phenotype...
7.
Georgescu M, Balanant J, Ozden S, Crainic R
J Gen Virol
. 1997 Aug;
78 ( Pt 8):1819-28.
PMID: 9266975
Mixed infections occur in the natural environment, and also result from the use of mixed live vaccines. Some recipients of the trivalent oral poliovirus vaccine develop vaccine-associated paralytic poliomyelitis (VAPP)....
8.
Crainic R, Wu R, Otelea D, Georgescu M, Delpeyroux F, Guillot S, et al.
Dev Biol Stand
. 1996 Jan;
87:161-6.
PMID: 8854013
The poliomyelitis eradication programme relies largely on the massive administration of the oral poliovirus vaccine (OPV). The major difficulty in assuring good vaccine coverage, especially in hot climates, is the...
9.
Wu R, Georgescu M, Delpeyroux F, Guillot S, Balanant J, Simpson K, et al.
Vaccine
. 1995 Aug;
13(12):1058-63.
PMID: 7491812
Eradication of poliomyelitis is based on the mass administration of oral poliovirus vaccine (OPV). Delivery of effective vaccines in the developing world, especially in tropical areas, is compromised when refrigeration...
10.
Georgescu M, Delpeyroux F, Tardy-Panit M, Balanant J, Combiescu M, Combiescu A, et al.
J Virol
. 1994 Dec;
68(12):8089-101.
PMID: 7966599
To establish the etiology of vaccine-associated paralytic poliomyelitis (VAPP), isolates from the central nervous system (CNS) from eight patients with VAPP were compared with stool isolates from the same patients....